1.43
-0.07 (-4.67%)
| 前收盘价格 | 1.50 |
| 收盘价格 | 1.46 |
| 成交量 | 34,320 |
| 平均成交量 (3个月) | 211,819 |
| 市值 | 9,700,462 |
| 市盈率 (P/E TTM) | 11.92 |
| 价格/销量 (P/S) | 1.44 |
| 股市价格/股市净资产 (P/B) | 2.00 |
| 52周波幅 |
| 营业利益率 (TTM) | -372.76% |
| 稀释每股收益 (EPS TTM) | 0.120 |
| 季度收入增长率 (YOY) | -20.50% |
| 总债务/股东权益 (D/E MRQ) | 14.89% |
| 流动比率 (MRQ) | 0.920 |
| 营业现金流 (OCF TTM) | -10.10 M |
| 杠杆自由现金流 (LFCF TTM) | -6.07 M |
| 资产报酬率 (ROA TTM) | -76.78% |
| 股东权益报酬率 (ROE TTM) | -291.77% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 看跌 | 混合的 |
| Medical Devices (全球的) | 看跌 | 混合的 | |
| 股票 | Intelligent Bio Solutions Inc. | - | - |
AIStockmoo 评分
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 5.0 |
| 技术振荡指标 | 0.0 |
| 平均 | 0.25 |
|
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment). |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 1.40% |
| 机构持股比例 | 1.27% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合